Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-10 4:26 pm Purchase | 13G | ROIVANT SCIENCES LTD SHS ROIV | Dexcel Pharma Technologies Ltd. | 98,809,158 14.28% | 98,809,158 (New Position) | View |
| 2022-02-01 4:06 pm Purchase | 13G | ROIVANT SCIENCES LTD SHS ROIV | Sumitomo Chemical Co. Ltd. | 86,367,360 12.48% | 86,367,360 (New Position) | View |
| 2021-10-20 5:13 pm Purchase | 13D | ARBUTUS BIOPHARMA CORP ABUS | Roivant Sciences Ltd. ROIV | 38,847,462 29.1% | 22,833,922 (+142.59%) | View |
| 2021-08-02 08:23 am Purchase | 13D | IMMUNOVANT INC IMVT | Roivant Sciences Ltd. ROIV | 73,398,664 63.8% | 17,021,276 (+30.19%) | View |
| 2021-03-08 08:00 am Unchanged | 13D | IMMUNOVANT INC IMVT | Roivant Sciences Ltd. ROIV | 56,377,388 57.5% | 0 (Unchanged) | View |
| 2020-09-18 4:32 pm Purchase | 13D | IMMUNOVANT INC IMVT | Roivant Sciences Ltd. ROIV | 56,377,388 57.6% | 8,773,969 (+18.43%) | View |
| 2020-09-04 5:29 pm Purchase | 13D | IMMUNOVANT INC IMVT | Roivant Sciences Ltd. ROIV | 47,603,419 54.2% | 380,000 (+0.80%) | View |
| 2020-05-14 7:24 pm Purchase | 13D | IMMUNOVANT INC IMVT | Roivant Sciences Ltd. ROIV | 47,223,419 62.1% | 8,773,969 (+22.82%) | View |
| 2020-04-17 5:27 pm Purchase | 13D | IMMUNOVANT INC IMVT | Roivant Sciences Ltd. ROIV | 38,449,450 58.2% | 1,034,483 (+2.76%) | View |
| 2020-02-27 9:59 pm Purchase | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Roivant Sciences Ltd. ROIV | 18,577,380 47.1% | 5,333,333 (+40.27%) | View |
| 2019-12-31 4:45 pm Unchanged | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Roivant Sciences Ltd. ROIV | 13,244,047 58.1% | 0 (Unchanged) | View |
| 2019-12-31 4:45 pm Sale | 13D | MYOVANT SCIENCES LTD COM MYOV | Roivant Sciences Ltd. ROIV | 0 0% | -44,509,411 (Position Closed) | View |
| 2019-12-31 4:45 pm Sale | 13D | UROVANT SCIENCES LTD SHS UROV | Roivant Sciences Ltd. ROIV | 0 0% | -22,860,013 (Position Closed) | View |
| 2019-12-20 5:26 pm Purchase | 13D | IMMUNOVANT INC IMVT | Roivant Sciences Ltd. ROIV | 37,414,967 66.3% | 37,414,967 (New Position) | View |
| 2019-11-27 4:45 pm Purchase | 13D | MYOVANT SCIENCES LTD COM MYOV | Roivant Sciences Ltd. ROIV | 44,509,411 49.7% | 3,743,812 (+9.18%) | View |
| 2019-11-04 06:05 am Unchanged | 13D | UROVANT SCIENCES LTD SHS UROV | Roivant Sciences Ltd. ROIV | 22,860,013 75.4% | 0 (Unchanged) | View |
| 2019-11-04 06:05 am Unchanged | 13D | MYOVANT SCIENCES LTD COM MYOV | Roivant Sciences Ltd. ROIV | 40,765,599 45.5% | 0 (Unchanged) | View |
| 2019-09-06 5:06 pm Unchanged | 13D | AXOVANT GENE THERAPIES LTD COM AXGT | Roivant Sciences Ltd. ROIV | 13,244,047 58.1% | 0 (Unchanged) | View |
| 2019-09-06 5:06 pm Unchanged | 13D | UROVANT SCIENCES LTD SHS UROV | Roivant Sciences Ltd. ROIV | 22,860,013 75.4% | 0 (Unchanged) | View |
| 2019-09-06 5:06 pm Unchanged | 13D | MYOVANT SCIENCES LTD COM MYOV | Roivant Sciences Ltd. ROIV | 40,765,599 45.5% | 0 (Unchanged) | View |